Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
R&D
Agency Leadership
Compliance
Complete Response Letters
Drug Review Profiles
Scrip
Amgen Calls For Balance To Support Biosimilars
US Firm Urges Science-Based Education And Policies That Facilitate Competition
Jul 12 2022
•
By
Dave Wallace
Amgen sets out its unique perspective on biosimilars • Source: Shutterstock
More from Biosimilars
More from Products